MDA
GILD icon

Minot DeBlois Advisors’s Gilead Sciences GILD Stock Holding History

Minot DeBlois Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-50
Closed -$5.55K – 227
2025
Q3 		$5.55K Hold
50
– – 0.01% 177
2025
Q2 		$5.54K Sell
50
-25
-33% -$2.66K 0.01% 187
2025
Q1 		$8.4K Sell
75
-115
-61% -$11.9K 0.01% 165
2024
Q4 		$17.6K Buy
+190
New +$17.1K 0.02% 172

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Minot DeBlois Advisors's GILD Position: Q4 2025 in Review

Minot DeBlois Advisors sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 50 shares — an estimated $5.55K sold.

Minot DeBlois Advisors first reported a position in GILD in Q4 2024 and held it in 4 quarters. The position peaked at $17.6K in Q4 2024. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Minot DeBlois Advisors reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Minot DeBlois Advisors sold 50 Gilead Sciences shares in Q4 2025, an estimated $5.55K.
  • Minot DeBlois Advisors first reported a position in Gilead Sciences in Q4 2024 and held it in 4 quarters.
  • Minot DeBlois Advisors's Gilead Sciences position peaked at $17.6K in Q4 2024.
  • 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Minot DeBlois Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.